COMMUNIQUÉ DE PRESSE publié le 22/10/2025 à 13:30, il y a 6 mois 2 jours Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRÈVE publiée le 13/10/2025 à 13:35, il y a 6 mois 11 jours Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025 Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRÈVE publiée le 13/10/2025 à 13:35, il y a 6 mois 11 jours Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025 Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
COMMUNIQUÉ DE PRESSE publié le 13/10/2025 à 13:30, il y a 6 mois 11 jours Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer) Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRÈVE publiée le 07/10/2025 à 13:35, il y a 6 mois 17 jours Medicus Pharma participera au sommet des family offices de Dubaï Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRÈVE publiée le 07/10/2025 à 13:35, il y a 6 mois 17 jours Medicus Pharma to Participate in Dubai Family Office Summit Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
COMMUNIQUÉ DE PRESSE publié le 07/10/2025 à 13:30, il y a 6 mois 17 jours Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRÈVE publiée le 29/09/2025 à 13:35, il y a 6 mois 25 jours Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRÈVE publiée le 29/09/2025 à 13:35, il y a 6 mois 25 jours Medicus Pharma Ltd. Gains FDA Support for Skinject Development FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
COMMUNIQUÉ DE PRESSE publié le 29/09/2025 à 13:30, il y a 6 mois 25 jours Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026 FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
Publié le 24/04/2026 à 18:48, il y a 10 heures 40 minutes Laboratoires Euromedis - Communiqué résultat 2025
Publié le 24/04/2026 à 18:00, il y a 11 heures 29 minutes SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Publié le 24/04/2026 à 17:45, il y a 11 heures 44 minutes Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Publié le 25/04/2026 à 03:10, il y a 2 heures 19 minutes BEACN Announces Financial Results for Year Ended December 31, 2025
Publié le 24/04/2026 à 22:05, il y a 7 heures 24 minutes Critical Elements Mourns the Loss of Director Marc Simpson
Publié le 24/04/2026 à 22:05, il y a 7 heures 24 minutes Critical Elements Pleure la perte de son administrateur Marc Simpson
Publié le 24/04/2026 à 22:00, il y a 7 heures 29 minutes Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Publié le 24/04/2026 à 15:00, il y a 14 heures 29 minutes Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Publié le 24/04/2026 à 22:43, il y a 6 heures 45 minutes EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Publié le 24/04/2026 à 22:05, il y a 7 heures 24 minutes Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Publié le 24/04/2026 à 18:30, il y a 10 heures 59 minutes EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Publié le 24/04/2026 à 18:12, il y a 11 heures 16 minutes EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Publié le 24/04/2026 à 18:07, il y a 11 heures 21 minutes DEAG sets new records for revenue and earnings in financial year 2025 – excellently positioned for long-term growth